https://cancerandmetabolism.biomedcentral.com/articles/10.1186/s40170-016-0154-8 Novel drugs that target the metabolic reprogramming in renal cell cancer Molecular profiling studies of tumor tissue from patients with clear cell renal cell cancer (ccRCC) have revealed extensive metabolic reprogramming in this disease. Associations were found between metabolic reprogramming, histopathologic Fuhrma..
